 | • レポートコード：D0GIR-00128 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、駆虫薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。駆虫薬の種類別市場規模（駆虫剤、抗原虫剤、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Ipca Laboratories Ltd、Novartis AG、Pfizer、Zydus Cadila、Ranbaxy Laboratories、Merck、Bayer AG、Cipla Ltd、GlaxoSmithKline Plc.、Alvizia Health Care、Alkem Laboratories Limited、Roche Inc、AstraZeneca、Arbor Pharmaceuticals Inc.、Sanofi ・地域別グローバル市場分析 2015年-2020年 ・駆虫薬の北米市場（アメリカ、カナダ、メキシコ） ・駆虫薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・駆虫薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・駆虫薬の南米市場（ブラジル、アルゼンチン） ・駆虫薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：駆虫剤、抗原虫剤、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Antiparasitic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Antiparasitic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Antiparasitic Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antiparasitic Drugs market has been segmented into:
Anthelmintics
Antiprotozoals
Others
By Application, Antiparasitic Drugs has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antiparasitic Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Antiparasitic Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antiparasitic Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Antiparasitic Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Antiparasitic Drugs Market Share Analysis
Antiparasitic Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antiparasitic Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antiparasitic Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Antiparasitic Drugs are:
Ipca Laboratories Ltd
Novartis AG
Pfizer
Zydus Cadila
Ranbaxy Laboratories
Merck
Bayer AG
Cipla Ltd
GlaxoSmithKline Plc.
Alvizia Health Care
Alkem Laboratories Limited
Roche Inc
AstraZeneca
Arbor Pharmaceuticals Inc.
Sanofi
Among other players domestic and global, Antiparasitic Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Antiparasitic Drugs Market Overview
1.1 Product Overview and Scope of Antiparasitic Drugs
1.2 Classification of Antiparasitic Drugs by Type
1.2.1 Global Antiparasitic Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antiparasitic Drugs Revenue Market Share by Type in 2019
1.2.3 Anthelmintics
1.2.4 Antiprotozoals
1.2.5 Others
1.3 Global Antiparasitic Drugs Market by Application
1.3.1 Overview: Global Antiparasitic Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Antiparasitic Drugs Market by Regions
1.4.1 Global Antiparasitic Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antiparasitic Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antiparasitic Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antiparasitic Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antiparasitic Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antiparasitic Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antiparasitic Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ipca Laboratories Ltd
2.1.1 Ipca Laboratories Ltd Details
2.1.2 Ipca Laboratories Ltd Major Business
2.1.3 Ipca Laboratories Ltd SWOT Analysis
2.1.4 Ipca Laboratories Ltd Product and Services
2.1.5 Ipca Laboratories Ltd Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG SWOT Analysis
2.2.4 Novartis AG Product and Services
2.2.5 Novartis AG Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Zydus Cadila
2.4.1 Zydus Cadila Details
2.4.2 Zydus Cadila Major Business
2.4.3 Zydus Cadila SWOT Analysis
2.4.4 Zydus Cadila Product and Services
2.4.5 Zydus Cadila Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ranbaxy Laboratories
2.5.1 Ranbaxy Laboratories Details
2.5.2 Ranbaxy Laboratories Major Business
2.5.3 Ranbaxy Laboratories SWOT Analysis
2.5.4 Ranbaxy Laboratories Product and Services
2.5.5 Ranbaxy Laboratories Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Product and Services
2.6.4 Merck Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Product and Services
2.7.4 Bayer AG Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Cipla Ltd
2.8.1 Cipla Ltd Details
2.8.2 Cipla Ltd Major Business
2.8.3 Cipla Ltd Product and Services
2.8.4 Cipla Ltd Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline Plc.
2.9.1 GlaxoSmithKline Plc. Details
2.9.2 GlaxoSmithKline Plc. Major Business
2.9.3 GlaxoSmithKline Plc. Product and Services
2.9.4 GlaxoSmithKline Plc. Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Alvizia Health Care
2.10.1 Alvizia Health Care Details
2.10.2 Alvizia Health Care Major Business
2.10.3 Alvizia Health Care Product and Services
2.10.4 Alvizia Health Care Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Alkem Laboratories Limited
2.11.1 Alkem Laboratories Limited Details
2.11.2 Alkem Laboratories Limited Major Business
2.11.3 Alkem Laboratories Limited Product and Services
2.11.4 Alkem Laboratories Limited Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Roche Inc
2.12.1 Roche Inc Details
2.12.2 Roche Inc Major Business
2.12.3 Roche Inc Product and Services
2.12.4 Roche Inc Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business
2.13.3 AstraZeneca Product and Services
2.13.4 AstraZeneca Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Arbor Pharmaceuticals Inc.
2.14.1 Arbor Pharmaceuticals Inc. Details
2.14.2 Arbor Pharmaceuticals Inc. Major Business
2.14.3 Arbor Pharmaceuticals Inc. Product and Services
2.14.4 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sanofi
2.15.1 Sanofi Details
2.15.2 Sanofi Major Business
2.15.3 Sanofi Product and Services
2.15.4 Sanofi Antiparasitic Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antiparasitic Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antiparasitic Drugs Players Market Share
3.2.2 Top 10 Antiparasitic Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antiparasitic Drugs Revenue and Market Share by Regions
4.2 North America Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
5 North America Antiparasitic Drugs Revenue by Countries
5.1 North America Antiparasitic Drugs Revenue by Countries (2015-2020)
5.2 USA Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
6 Europe Antiparasitic Drugs Revenue by Countries
6.1 Europe Antiparasitic Drugs Revenue by Countries (2015-2020)
6.2 Germany Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
6.4 France Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antiparasitic Drugs Revenue by Countries
7.1 Asia-Pacific Antiparasitic Drugs Revenue by Countries (2015-2020)
7.2 China Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
7.5 India Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
8 South America Antiparasitic Drugs Revenue by Countries
8.1 South America Antiparasitic Drugs Revenue by Countries (2015-2020)
8.2 Brazil Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antiparasitic Drugs by Countries
9.1 Middle East & Africa Antiparasitic Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antiparasitic Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Antiparasitic Drugs Market Forecast by Type (2019-2024)
10.3 Anthelmintics Revenue Growth Rate (2015-2025)
10.4 Antiprotozoals Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Antiparasitic Drugs Market Segment by Application
11.1 Global Antiparasitic Drugs Revenue Market Share by Application (2015-2020)
11.2 Antiparasitic Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Antiparasitic Drugs Market Size Forecast (2021-2025)
12.1 Global Antiparasitic Drugs Market Size Forecast (2021-2025)
12.2 Global Antiparasitic Drugs Market Forecast by Regions (2021-2025)
12.3 North America Antiparasitic Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Antiparasitic Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antiparasitic Drugs Revenue Market Forecast (2021-2025)
12.6 South America Antiparasitic Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antiparasitic Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Antiparasitic Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antiparasitic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antiparasitic Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Antiparasitic Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Antiparasitic Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Ipca Laboratories Ltd Corporate Information, Location and Competitors
Table 7. Ipca Laboratories Ltd Antiparasitic Drugs Major Business
Table 8. Ipca Laboratories Ltd Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 9. Ipca Laboratories Ltd SWOT Analysis
Table 10. Ipca Laboratories Ltd Antiparasitic Drugs Product and Solutions
Table 11. Ipca Laboratories Ltd Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novartis AG Corporate Information, Location and Competitors
Table 13. Novartis AG Antiparasitic Drugs Major Business
Table 14. Novartis AG Antiparasitic Drugs Total Revenue (USD Million) (2018-2019)
Table 15. Novartis AG SWOT Analysis
Table 16. Novartis AG Antiparasitic Drugs Product and Solutions
Table 17. Novartis AG Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Pfizer Corporate Information, Location and Competitors
Table 19. Pfizer Antiparasitic Drugs Major Business
Table 20. Pfizer Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 21. Pfizer SWOT Analysis
Table 22. Pfizer Antiparasitic Drugs Product and Solutions
Table 23. Pfizer Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Zydus Cadila Corporate Information, Location and Competitors
Table 25. Zydus Cadila Antiparasitic Drugs Major Business
Table 26. Zydus Cadila Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 27. Zydus Cadila SWOT Analysis
Table 28. Zydus Cadila Antiparasitic Drugs Product and Solutions
Table 29. Zydus Cadila Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Ranbaxy Laboratories Corporate Information, Location and Competitors
Table 31. Ranbaxy Laboratories Antiparasitic Drugs Major Business
Table 32. Ranbaxy Laboratories Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 33. Ranbaxy Laboratories SWOT Analysis
Table 34. Ranbaxy Laboratories Antiparasitic Drugs Product and Solutions
Table 35. Ranbaxy Laboratories Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Merck Corporate Information, Location and Competitors
Table 37. Merck Antiparasitic Drugs Major Business
Table 38. Merck Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 39. Merck SWOT Analysis
Table 40. Merck Antiparasitic Drugs Product and Solutions
Table 41. Merck Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Bayer AG Corporate Information, Location and Competitors
Table 43. Bayer AG Antiparasitic Drugs Major Business
Table 44. Bayer AG Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 45. Bayer AG SWOT Analysis
Table 46. Bayer AG Antiparasitic Drugs Product and Solutions
Table 47. Bayer AG Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Cipla Ltd Corporate Information, Location and Competitors
Table 49. Cipla Ltd Antiparasitic Drugs Major Business
Table 50. Cipla Ltd Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 51. Cipla Ltd SWOT Analysis
Table 52. Cipla Ltd Antiparasitic Drugs Product and Solutions
Table 53. Cipla Ltd Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. GlaxoSmithKline Plc. Corporate Information, Location and Competitors
Table 55. GlaxoSmithKline Plc. Antiparasitic Drugs Major Business
Table 56. GlaxoSmithKline Plc. Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 57. GlaxoSmithKline Plc. SWOT Analysis
Table 58. GlaxoSmithKline Plc. Antiparasitic Drugs Product and Solutions
Table 59. GlaxoSmithKline Plc. Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Alvizia Health Care Corporate Information, Location and Competitors
Table 61. Alvizia Health Care Antiparasitic Drugs Major Business
Table 62. Alvizia Health Care Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 63. Alvizia Health Care SWOT Analysis
Table 64. Alvizia Health Care Antiparasitic Drugs Product and Solutions
Table 65. Alvizia Health Care Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Alkem Laboratories Limited Corporate Information, Location and Competitors
Table 67. Alkem Laboratories Limited Antiparasitic Drugs Major Business
Table 68. Alkem Laboratories Limited Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 69. Alkem Laboratories Limited SWOT Analysis
Table 70. Alkem Laboratories Limited Antiparasitic Drugs Product and Solutions
Table 71. Alkem Laboratories Limited Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Roche Inc Corporate Information, Location and Competitors
Table 73. Roche Inc Antiparasitic Drugs Major Business
Table 74. Roche Inc Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 75. Roche Inc SWOT Analysis
Table 76. Roche Inc Antiparasitic Drugs Product and Solutions
Table 77. Roche Inc Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. AstraZeneca Corporate Information, Location and Competitors
Table 79. AstraZeneca Antiparasitic Drugs Major Business
Table 80. AstraZeneca Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 81. AstraZeneca SWOT Analysis
Table 82. AstraZeneca Antiparasitic Drugs Product and Solutions
Table 83. AstraZeneca Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Arbor Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 85. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Major Business
Table 86. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 87. Arbor Pharmaceuticals Inc. SWOT Analysis
Table 88. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Product and Solutions
Table 89. Arbor Pharmaceuticals Inc. Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Sanofi Corporate Information, Location and Competitors
Table 91. Sanofi Antiparasitic Drugs Major Business
Table 92. Sanofi Antiparasitic Drugs Total Revenue (USD Million) (2017-2018)
Table 93. Sanofi SWOT Analysis
Table 94. Sanofi Antiparasitic Drugs Product and Solutions
Table 95. Sanofi Antiparasitic Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Antiparasitic Drugs Revenue (Million USD) by Players (2015-2020)
Table 97. Global Antiparasitic Drugs Revenue Share by Players (2015-2020)
Table 98. Global Antiparasitic Drugs Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Antiparasitic Drugs Revenue Market Share by Regions (2015-2020)
Table 100. North America Antiparasitic Drugs Revenue by Countries (2015-2020)
Table 101. North America Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Table 102. Europe Antiparasitic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Antiparasitic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Antiparasitic Drugs Revenue by Countries (2015-2020)
Table 105. South America Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Antiparasitic Drugs Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Antiparasitic Drugs Revenue (Million USD) by Type (2015-2020)
Table 109. Global Antiparasitic Drugs Revenue Share by Type (2015-2020)
Table 110. Global Antiparasitic Drugs Revenue Forecast by Type (2021-2025)
Table 111. Global Antiparasitic Drugs Revenue by Application (2015-2020)
Table 112. Global Antiparasitic Drugs Revenue Share by Application (2015-2020)
Table 113. Global Antiparasitic Drugs Revenue Forecast by Application (2021-2025)
Table 114. Global Antiparasitic Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Antiparasitic Drugs Picture
Figure 2. Global Antiparasitic Drugs Revenue Market Share by Type in 2019
Figure 3. Anthelmintics Picture
Figure 4. Antiprotozoals Picture
Figure 5. Others Picture
Figure 6. Antiparasitic Drugs Revenue Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Others Picture
Figure 10. Global Antiparasitic Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Antiparasitic Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Antiparasitic Drugs Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Antiparasitic Drugs Revenue Market Share in 2019
Figure 19. Global Top 10 Players Antiparasitic Drugs Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Antiparasitic Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Antiparasitic Drugs Revenue Market Share by Regions (2015-2020)
Figure 23. Global Antiparasitic Drugs Revenue Market Share by Regions in 2018
Figure 24. North America Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 25. Europe Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 27. South America Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 29. North America Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Figure 30. North America Antiparasitic Drugs Revenue Market Share by Countries in 2019
Figure 31. USA Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Canada Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Europe Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Antiparasitic Drugs Revenue Market Share by Countries in 2019
Figure 36. Germany Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 37. UK Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 38. France Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Russia Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Italy Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Antiparasitic Drugs Revenue Market Share by Countries in 2019
Figure 43. China Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Japan Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Korea Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 46. India Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 48. South America Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Figure 49. South America Antiparasitic Drugs Revenue Market Share by Countries in 2019
Figure 50. Brazil Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Antiparasitic Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Antiparasitic Drugs Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 55. UAE Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Antiparasitic Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Global Antiparasitic Drugs Revenue Share by Type (2015-2020)
Figure 59. Global Antiparasitic Drugs Revenue Share by Type in 2019
Figure 60. Global Antiparasitic Drugs Market Share Forecast by Type (2021-2025)
Figure 61. Global Anthelmintics Revenue Growth Rate (2015-2020)
Figure 62. Global Antiprotozoals Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Antiparasitic Drugs Revenue Share by Application (2015-2020)
Figure 65. Global Antiparasitic Drugs Revenue Share by Application in 2019
Figure 66. Global Antiparasitic Drugs Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Revenue Growth Rate (2015-2020)
Figure 68. Global Clinic Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Antiparasitic Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Antiparasitic Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Antiparasitic Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Antiparasitic Drugs Revenue Market Forecast (2021-2025)
Figure 74. Europe Antiparasitic Drugs Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Antiparasitic Drugs Revenue Market Forecast (2021-2025)
Figure 76. South America Antiparasitic Drugs Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Antiparasitic Drugs Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
泌尿生殖器薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…- 先端巨大症・巨人症治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acromegaly and Gigantism Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acromegaly and…
- 糖尿病用注射薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drugs For Diabetes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 眼瞼炎治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Blepharitis Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- アトピー性皮膚炎治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Atopic Dermatitis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Atopic Dermatitis Dru…